FOXO4-DRI (Proxofim) (10mg)

$270.00

FOXO4-DRI (Proxofim) (10mg) is offered by Biotech Peptides for laboratory and analytical research. FOXO4-DRI is a synthetic D-retro-inverso peptide, also called Proxofim, studied in relation to FOXO4-p53 signaling and senescent-cell apoptosis. 1241

  • Product: FOXO4-DRI

  • Alternative name: Proxofim

  • Listed quantity: 10 mg

  • Reference molecular formula: C₂₂₈H₃₈₈N₈₆O₆₄

  • Intended use: Laboratory and analytical research only

Review the manufacturer specifications and applicable analytical documentation before selecting material for your protocol.

For research use only. Not for human consumption.

SKU: FOXO4-DRI-10mg Category:
Description

FOXO4-DRI (Proxofim) (10mg) for Laboratory Research

FOXO4-DRI (Proxofim) (10mg) is offered by Biotech Peptides for laboratories investigating FOXO4-p53 signaling, cellular senescence, and senolytic pathways. FOXO4-DRI is a synthetic D-retro-inverso peptide, also called Proxofim, that is an all-D amino acid variant of a FOXO4-derived sequence. 1241

For laboratories looking to buy FOXO4-DRI, this listing identifies a 10 mg quantity. Confirm the supplied material’s salt state, stereochemistry, and analytical characteristics against the requirements of the intended work.

Explore our research peptides for sale to review other laboratory-use listings.

FOXO4-DRI Product Information

Property Listing information
Product name FOXO4-DRI
Alternative name Proxofim
Listed quantity 10 mg
Intended application Laboratory and analytical research
Documentation inquiries Include the product name and batch or lot number, where available

The 10 mg designation describes the quantity stated for this listing. It does not independently establish net peptide content or confirm that a particular quantity-assay method has been performed.

FOXO4-DRI Reference Molecular Characteristics

The following characteristics describe the FOXO4-DRI reference structure. They are not analytical confirmation of an individual commercial batch.

Reference characteristic Information
Peptide class D-retro-inverso peptide
Reference sequence H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
Molecular formula C₂₂₈H₃₈₈N₈₆O₆₄
Approximate molecular weight 5358.05 g/mol
Chemical class Synthetic all-D peptide

The sequence, molecular formula, and molecular weight are documented in the primary FOXO4-DRI senescence study and in the FOXO4-DRI research summary. Confirm the supplied salt state and any counterions against manufacturer specifications before using reference values in analytical calculations. 1241

FOXO4-DRI and Senescence Research

A study of FOXO4-DRI and senescent cells reported that FOXO4-DRI potently and selectively reduces the viability of senescent cells by competing with FOXO4-p53 binding. The investigators reported that in senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic apoptosis. 1241

A separate study of FOXO4-DRI and senescent cells reported that FOXO4-DRI selectively induces p53 nuclear exclusion and apoptosis in senescent Leydig cells. The investigators reported that in naturally aged mice, FOXO4-DRI improved the testicular microenvironment and alleviated age-related testosterone secretion insufficiency. 1242

These findings apply to specific cell models and animal studies. They do not establish that a commercial FOXO4-DRI batch removes senescent cells, improves tissue function, or produces a cosmetic effect in humans. 1241

Research Limitations

Published FOXO4-DRI research examines receptor signaling, cell-based assays, and animal models. It does not establish that FOXO4-DRI treats aging, cancer, or any other condition. 1241

Published research also does not verify the identity, purity, quantity, or biological activity of the commercial batch supplied with this listing.

Documentation and Batch Verification

Before selecting FOXO4-DRI (Proxofim) (10mg), review the information associated with the exact material being supplied. Depending on your protocol, relevant documentation may include:

  • Product name and batch or lot identifier.

  • Manufacturer specifications and chemical form.

  • Salt state and counterion information, where applicable.

  • Identity-testing methods and reported results.

  • Purity-testing methods and supporting analytical data.

  • Quantity or peptide-content measurements, where required.

  • Product-specific storage and handling instructions.

Match identifiers across the label, specifications, and analytical reports. Obtain clarification if the documentation uses inconsistent names, sequences, or molecular values.

For inquiries, provide “FOXO4-DRI (Proxofim) (10mg),” the batch number where available, and the specific information your laboratory requires.

Storage and Handling

Follow the product-specific instructions supplied with the material and your laboratory’s applicable procedures.

Do not transfer storage temperatures, shelf-life claims, or preparation instructions from another supplier’s formulation or a differently modified peptide. Obtain clarification if documented instructions are unavailable or unclear.

Frequently Asked Questions About FOXO4-DRI (Proxofim) (10mg)

What is FOXO4-DRI?

FOXO4-DRI is a synthetic D-retro-inverso peptide, also called Proxofim, that is an all-D amino acid variant of a FOXO4-derived sequence. 1241

Is FOXO4-DRI the same as Proxofim?

Yes. FOXO4-DRI and Proxofim refer to the same molecule. 1241

Does FOXO4-DRI remove senescent cells?

A study of FOXO4-DRI and senescent cells reported that FOXO4-DRI potently and selectively reduces the viability of senescent cells by competing with FOXO4-p53 binding. This does not establish that a commercial FOXO4-DRI batch removes senescent cells in humans. 1241

What does the 10mg designation mean?

It is the quantity stated for this listing. It does not describe a concentration or independently establish net peptide content.

Does published research verify this product?

No. Publications describe the materials and conditions used by the investigators. Assess a commercial batch using relevant manufacturer specifications and analytical evidence.

Where can I find delivery information?

Review our shipping information for current order-processing and delivery terms.

Research Use Only

FOXO4-DRI (Proxofim) (10mg) is sold for laboratory and analytical research only. Not for human or animal consumption, personal administration, medical treatment, diagnosis, or veterinary application.

Review our Research-Use-Only Policy before ordering.

Additional information
BrandBiotech Peptides
Shipping & Delivery